Phase 2 Non-Alcoholic Fatty Liver Disease Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Non-Alcoholic Fatty Liver Disease
Justin Ryder40 enrolled1 locationNCT06355310
Recruiting
Phase 2
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Phase 2
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
Non-Alcoholic Fatty Liver Disease
Tanta University46 enrolled1 locationNCT06863376
Recruiting
Phase 2
Soluble Fibre Supplementation in NAFLD
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisHepatic Steatosis
McMaster University60 enrolled1 locationNCT05480696
Recruiting
Phase 2
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisMicrobiome+4 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)48 enrolled1 locationNCT05821010
Recruiting
Phase 2
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki44 enrolled1 locationNCT06133101